ライフサイエンスコーパス: Shigella sonnei

1 e excursions (three outbreaks, one caused by Shigella sonnei).

2 0% against Shigella flexneri and 50% against Shigella sonnei.

3 lmonary infection with Shigella flexneri and Shigella sonnei.

4 echnologists (22%) developed infections with Shigella sonnei.

5 2015, focussing on Shigella flexneri 2a and Shigella sonnei.

6 , including 49 Shigella flexneri (33%) and 3 Shigella sonnei (0.3%) isolates.

7 The most common species and serotypes were Shigella sonnei (366 [30.4%] of 1202), S flexneri 2a (25

8 riod, the highest proportion of isolates was Shigella sonnei (54.4%), followed by S. flexneri (39.2%)

9 Shigella flexneri was more common than Shigella sonnei (58% vs 36%); however, S. sonnei constit

10 terial dysentery, with Shigella flexneri and Shigella sonnei accounting for around 90% of cases world

11 Shigella sonnei and Salmonella Typhi cause significant m

12 for membrane antigens-based vaccine against Shigella sonnei and Shigella flexneri 1b, 2a, and 3a (al

13 erase genes, msbB or htrB, in GMMA-producing Shigella sonnei and Shigella flexneri strains.

14 Salmonella enteritidis, Salmonella arizonae, Shigella sonnei, and Shigella dysenteriae serotypes 1, 2

15 hat SHI-2 is present in the same location in Shigella sonnei, but the aerobactin genes are not locate

16 ocytogenes, Salmonella entericaserovartyphi, Shigella sonnei, Campylobacter jejuni and Helicobacter p

17 Shigella sonnei causes shigellosis, a severe gastrointes

18 n extended-spectrum beta-lactamase-producing Shigella sonnei cluster of 9 patients was identified in

19 b ColJs plasmid of a colicinogenic strain of Shigella sonnei (colicin type 7) was isolated and sequen

20 horylation intermediate (E2.Pi) of ZntA from Shigella sonnei, determined at 3.2 A and 2.7 A resolutio

21 The gene region for biosynthesis of Shigella sonnei form I O polysaccharide (O-Ps) and flank

22 bal spread of ciprofloxacin-resistant (cipR) Shigella sonnei from 2010, fluoroquinolones remain the r

23 Antimicrobial resistance of Shigella sonnei has become a global concern.

24 Shigella sonnei has caused sexually transmitted enteric

25 analyze the largest surveillance data set of Shigella sonnei in the United States from 1967 to 2007 w

26 Shigella sonnei increasingly dominates the international

27 s a leading cause of diarrhoeal deaths, with Shigella sonnei increasingly implicated as a dominant ag

28 estigated an outbreak of multidrug-resistant Shigella sonnei infections in a retirement community tha

29 at clinical isolates of both S. flexneri and Shigella sonnei invade epithelial cells and are cytotoxi

30 Shigella sonnei is a bacterial pathogen and causative ag

31 Shigella sonnei is a human-adapted pathogen that is emer

32 Shigella sonnei is a major cause of diarrhoea globally a

33 Shigella sonnei is an important cause of bacterial dysen

34 Shigella sonnei is the most common agent of shigellosis

35 pecific multidrug-resistant (MDR) lineage of Shigella sonnei (lineage III) is becoming globally domin

36 pylori immunoglobulin (Ig) G and preexisting Shigella sonnei lipopolysaccharide IgG and IgA antibodie

37 Most isolates are Shigella sonnei, making it difficult to identify epidemi

38 linic because diarrhea and were positive for Shigella sonnei (n = 66), enterotoxigenic Escherichia co

39 and who were experimentally challenged with Shigella sonnei (non-endemic setting), and serum samples

40 o uronic acids, as already verified here for Shigella sonnei O-antigen, Streptococcus pneumoniae sero

41 In one study, the Shigella sonnei O-specific polysaccharide (O-SP)-protein

42 emiological data and a clinical trial with a Shigella sonnei O-specific polysaccharide (O-SP)-Pseudom

43 During 1994-1996, Shigella sonnei outbreaks occurred in 8 North American t

44 lt males, characterized by distinct periodic Shigella sonnei outbreaks.

45 The current Shigella sonnei pandemic involves geographically associa

46 al analysis of poly- and oligosaccharides of Shigella sonnei phase II ECA(LPS).

47 Here, we show that the Shigella sonnei rhomboid proteases GlpG and the newly id

48 Salmonella enteritidis, Salmonella arizonae, Shigella sonnei, Shigella dysenteriae, Campylobacter jej

49 ludes four serogroups: Shigella dysenteriae, Shigella sonnei, Shigella flexneri, and Shigella boydii.

50 using Shigella flexneri 2a strain 2457T and Shigella sonnei strain 53G.

51 Multi- and extensively drug-resistant Shigella sonnei strains associated with recent outbreaks

52 enic E. coli, enteroaggregative E. coli, and Shigella sonnei strains.

53 SM) community are attributed to 3 serotypes: Shigella sonnei unique serotype and Shigella flexneri 2a

54 s to evaluate WRSS1, a live, oral Delta virG Shigella sonnei vaccine candidate.

55 Construction of a stable Shigella sonnei vaccine has been complicated by the inst

56 ction studies using a combination vaccine of Shigella sonnei vaccine strain WRSS1, Shigella flexneri

57 e ipgDEF operon of the Shigella flexneri and Shigella sonnei virulence plasmid.

58 Sub-species analysis revealed Shigella sonnei was the most prevalent species among Shi